...
首页> 外文期刊>Urologic oncology >Continuous bladder irrigation prevents hemorrhagic cystitis after allogeneic hematopoietic cell transplantation.
【24h】

Continuous bladder irrigation prevents hemorrhagic cystitis after allogeneic hematopoietic cell transplantation.

机译:连续膀胱冲洗可防止异基因造血细胞移植后出血性膀胱炎。

获取原文
获取原文并翻译 | 示例
           

摘要

Hemorrhagic cystitis is 1 of the most troublesome complications of hematopoietic cell transplantation conditioning regimens. We conducted a nonrandomized controlled clinical study to investigate the role of continuous bladder irrigation in addition to mesna, hydration, and alkalization in the prevention of hemorrhagic cystitis after allogeneic hematopoietic cell transplantation. A total of 80 eligible patients entered the study. From May 2006, 40 patients who underwent allogeneic hematopoietic cell transplantation received continuous bladder irrigation in addition to the common protocol. A historical control group of 40 consecutive patients with same inclusion criteria who did not receive bladder irrigation was enrolled from before May 2006. Hemorrhagic cystitis occurred in 50% of patients in the no bladder irrigation group versus 32% in bladder irrigation group (P = 0.11). The mean duration of hemorrhagic cystitis was significantly reduced in the bladder irrigation group (10 vs. 18 days; P = 0.02). Duration of hospitalization was significantly shorter in the bladder irrigation group (30.2 vs. 39.6; P < 0.001). Late-onset hemorrhagic cystitis that occurred beyond 4 weeks after allo-hemorrhagic cystitis happened more significantly in the no bladder irrigation group (P = 0.001). High-grade hemorrhagic cystitis was more frequently associated with high-grade graft-versus-host disease within 30 days after transplant (P = 0.06). In general, continuous bladder irrigation added to mesna, hydration, and alkalization regimens was well tolerated, decreased the complications of hemorrhagic cystitis, and may be useful in hematopoietic cell transplantation patients. However, more investigations with randomized controlled clinical trials with more patients are needed.
机译:出血性膀胱炎是造血细胞移植调理方案最麻烦的并发症之一。我们进行了一项非随机对照临床研究,以研究异基因造血细胞移植后除梅斯纳,水合作用和碱化外,连续膀胱冲洗在预防出血性膀胱炎中的作用。共有80名合格患者进入研究。从2006年5月起,除常规方案外,还接受了40例接受同种异体造血细胞移植的患者的连续膀胱冲洗。从2006年5月开始,纳入了一个历史对照组,其中40例具有相同纳入标准的连续患者均未接受膀胱冲洗。无膀胱冲洗组的出血性膀胱炎发生率为50%,而膀胱冲洗组为32%(P = 0.11) )。在膀胱冲洗组中,出血性膀胱炎的平均持续时间显着减少(10天比18天; P = 0.02)。膀胱冲洗组住院时间明显缩短(30.2比39.6; P <0.001)。在非膀胱冲洗组中,同种异体出血性膀胱炎发生后超过4周的迟发性出血性膀胱炎发生率更高(P = 0.001)。移植后30天内,高等级出血性膀胱炎更常与高等级移植物抗宿主病相关(P = 0.06)。一般而言,连续注入膀胱液,水合作用和碱化方案可耐受性良好,可减少出血性膀胱炎的并发症,对造血细胞移植患者可能有用。但是,需要更多的针对更多患者的随机对照临床试验研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号